Kazia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.About KZIA
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.
CEOJohn E. Friend
CEOJohn E. Friend
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1994
Founded1994
Employees—
Employees—
KZIA Key Statistics
Market cap22.17M
Market cap22.17M
Price-Earnings ratio-1.06
Price-Earnings ratio-1.06
Dividend yield—
Dividend yield—
Average volume248.20K
Average volume248.20K
High today—
High today—
Low today—
Low today—
Open price$13.06
Open price$13.06
Volume0.00
Volume0.00
52 Week high$21.00
52 Week high$21.00
52 Week low$2.86
52 Week low$2.86
Stock Snapshot
As of today, Kazia Therapeutics(KZIA) shares are valued at $13.08. The company's market cap stands at 22.17M, with a P/E ratio of -1.06.
During the trading day, Kazia Therapeutics(KZIA) stock saw an opening price of $13.06, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 248.2K.
The stock's 52-week range extends from a low of $2.86 to a high of $21.00.
The stock's 52-week range extends from a low of $2.86 to a high of $21.00.
KZIA News
TipRanks 7d
Kazia Therapeutics Secures $46.5 Million Through Private Placement to Address Nasdaq ComplianceTipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...